To identify whether SMO or Gli-1 are directly regulated by Gal-1, we treated Gal-1-overexpressing gastric cancer cell lines with cyclopamine (a SMO antagonist) or a siRNA specific to SMO and Gli-1 in the presence of rGal-1. This evidence concerns the gene SMO and gastric cancer.